Intracranial Tumors Can Be Resected Safely in Elderly

This article originally appeared here.
Share this content:
Intracranial Tumors Can Be Resected Safely in Elderly
Intracranial Tumors Can Be Resected Safely in Elderly

(HealthDay News) -- Elderly patients do not have poorer short-term outcomes after surgical resection of primary or metastatic intracranial tumors, after accounting for other risk factors, according to research published online Oct. 12 in Cancer.

Andreea Seicean, M.P.H., of the Case Western Reserve University School of Medicine in Cleveland, and colleagues conducted a prospective study using data from the American College of Surgeons' National Surgical Quality-Improvement Project database from 2006 to 2010. Outcomes were assessed for 134 patients aged 75 years and older and 134 propensity score-matched patients aged 40 to 74 years of age who underwent craniotomy for resection of malignant brain tumors.

The researchers found no increase in the odds for poorer short-term outcomes with advanced age. There were no significant differences in minor or major complications between the groups, and no significant differences in return to the operating room or 30-day mortality.

"Contrary to common assumptions, our analysis of a large, prospective, multi-institutional database suggests that advanced age does not predispose individuals undergoing aggressive surgical therapy for primary or metastatic intracranial tumor to increased risk for operative or short-term postoperative morbidity or mortality," the authors write.


Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs